CLINACIN 150 MG ANTIBIOTIC TABLETS FOR DOGS
Šalis: Australija
kalba: anglų
Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)
Pakuotės lapelis
(PIL)
20-06-2017
Prekės savybės
(SPC)
20-06-2017
Veiklioji medžiaga:
CLINDAMYCIN AS CLINDAMYCIN HYDROCHLORIDE
Prieinama:
CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED
INN (Tarptautinis Pavadinimas):
clindamycin as HCl(150mg/Tb)
Vaisto forma:
ORAL TABLET
Sudėtis:
CLINDAMYCIN AS CLINDAMYCIN HYDROCHLORIDE ANTIBIOTIC Active 150.0 mg/Tb
Vienetai pakuotėje:
100 Tabs; 50 Tablets
Klasė:
VM - Veterinary Medicine
Pagaminta:
CHANELLE PHARMACEUTI
Farmakoterapinė grupė:
DOG | BITCH | CASTRATE | PUPPY
Gydymo sritis:
ANTIBIOTIC & RELATED
Terapinės indikacijos:
ACTINOMYCES SPP. | BACTEROIDES SPP. | CLOSTRIDIUM SPP. | DENTAL INFECTION | FUSOBACTERIUM SPP. | OSTEOMYELITIS | PEPTOSTREPTOCOCCUS SPP. | PROPIONIBACTERIUM SPP. | STAPHYLOCOCCUS AUREUS | STAPHYLOCOCCUS SPP. | STREPTOCOCCUS SPP. | WOUND INFECTIONS | ABSCESSES | ANAEROBIC BACTERIA | CLOSTRIDIUM BOTULINUM | CLOSTRIDIUM CHAUVOEI | CLOSTRIDIUM FALLAX | CLOSTRIDIUM FESERI | CLOSTRIDIUM HEMOLYTICUM | CLOSTRIDIUM NOVYI | CLOSTRIDIUM PERFRINGENS TYPES | CLOSTRIDIUM SEPTICUM | CLOSTRIDIUM SORDELLI | CLOSTRIDIUM SPOROGENES | CLOSTRIDIUM TETANI | INCLUDING B-LACTAMASE PRODUCIN | STAPHYLOCOCCOSIS
Produkto santrauka:
Poison schedule: 4; Withholding period: WHP: N/A.; Host/pest details: DOG: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., OSTEOMYELITIS, PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., OSTEOMYELITIS, PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; For the treatment of infected wounds, abscesses, dental infections and osteomyelitis in dogs where these infections are caused by bacteria susceptible to clindamycin.Contraindicated in rabbits, hamsters & guinea pigs and in other sensitive animals. Should not be used in cats for longer than 2 weeks. RESTRAINT: DO NOT USE in food producing species of animals or horses.
Autorizacija statusas:
Registered
Leidimo data:
2023-07-01
Pakuotės lapelis
LABEL IMAGE PROUDLY SUPPLIED BY
INFOPEST@DPI.QLD.GOV.AU
Perskaitykite visą dokumentą
Prekės savybės
PRODUCT NAME: CLINACIN ANTIBIOTIC TABLETS FOR DOGS AND CATS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
clindamycin is an antibiotic ingredient.
TRADE NAME:
CLINACIN ANTIBIOTIC TABLETS FOR DOGS AND CATS
PRODUCT CODE:
18934, 18935 and 18936
RECOMMENDED USE:
Antibiotic for treatment of dogs and cats (prescription animal
remedy).
APVMA NO:
57882, 57884, 57885
CREATION DATE:
June, 2007
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S22, S25, S45. Do not breathe dust. Avoid contact with eyes. In case
of accident or if you feel
unwell, contact a doctor or Poisons Information Centre immediately
(show this MSDS where possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
A round or oblong white tablet with a breakline on one side.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. The
active ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product as it
may cause sensitisation.
Adverse reactions associated with clindamycin treatment include:
diarrhoea, pseudomembranous colitis, nausea,
vomiting, abdominal pain/cramps, rash, and/or itch.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSU
Perskaitykite visą dokumentą
